Relmada Therapeutics, Inc. (RLMD)
5.71
-0.24
(-4.03%)
USD |
NASDAQ |
Jun 08, 16:00
5.79
+0.08
(+1.40%)
After-Hours: 19:25
Relmada Therapeutics Price : 5.71 for June 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Theravance Biopharma, Inc. | 16.30 |
| Indivior Pharmaceuticals, Inc. | 37.41 |
| ANI Pharmaceuticals, Inc. | 80.15 |
| Corcept Therapeutics, Inc. | 73.34 |
| Assertio Holdings, Inc. | 23.44 |
Price Related Metrics
| Price to Book Value | 2.738 |
| Earnings Yield | -19.48% |
| Market Cap | 598.92M |